Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Trial efficacy data (STEP 1, SURMOUNT-1) is from brand-name
The growing burden of chronic metabolic disorders worldwide, combined with increasing healthcare expenditures and stronger clinical emphasis on long-term weight management and glycemic control, is compelling healthcare providers, payers, and patients to adopt advanced GLP-1 agonist therapies
Stay active and healthy while taking the medication
Beylot-Barry M, Mahe E, Rolland C, de la Breteque MA, Eychenne C, Charles J, Payen C, Machet L, Vermorel C, Foote A, Roques C, Bosson JL (2022) Evaluation of the benefit of thermal spa therapy in plaque psoriasis: the PSOTHERMES randomized clinical trial
Advise patients who are exposed to WEGOVY during pregnancy to contact Novo Nordisk at 1-877-390-2760 or www.wegovypregnancyregistry.com [see Use in Specific Populations (8.1)]
News provided by Haleon Jul 18, 2022, 09:00 ET Maker of Sensodyne, Advil, and TUMS becomes one of the world's leading independent consumer health companies Demerger from GSK plc (GSK) now complete WARREN, N.J., July 18, 2022 /PRNewswire/ -- Today, Haleon (LSE/NYSE: HLN) launches as an independent company 100% focused on consumer health, completing its demerger from GSK
US$ 20.44
US$ 20.60
US$ 23.53
US$ 25.24
US$ 27.81
US$ 23.68
US$ 29.71
